RightFit
Not yet recruitingPhase 2

A1Cantus vs. Placebo

Double-Blind Randomized Controlled Trial of A1Cantus Drink vs. Placebo for Reduction of Ha1c

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
21 Years to 75 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests A1c Drink against a placebo drink in adults ages 21 to 75 with type 2 diabetes. It will compare changes over 3 months in A1c, a blood test that shows average blood sugar levels. Participants and study staff will not know which drink each person gets.

The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are 21 to 75 years old and are recruited from UCR Health.
  • You have type 2 diabetes and an A1c level from 8 to 10.
  • Your medicines have been stable for at least 6 months.
  • You speak Spanish, English, or both.
  • You sign a form agreeing to take part in the study.
  • No one else in your household is taking part in the study.

Who can't join

  • You are under 21, do not have type 2 diabetes, or have an A1c below 8 or above 10.
  • You have major diabetes problems, such as long-term kidney disease, diabetes-related eye damage, an ADVD risk score above 5, or a history of heart or blood vessel disease or stroke.
  • You do not speak and understand English or Spanish well.
  • You are allergic to cinnamon.
  • You have a severe disease, such as cancer, or a weakened immune system.
  • You have an eating disorder or a substance use disorder.
  • Your body mass index (BMI), a measure based on height and weight, is 40 or higher.
  • A family member is already taking part in the study.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Adults 21 years of age or older and not older than 75 recruited from UCR Health * Clinical diagnosis of type II DM with Ha1c \>= 8 but less than or equal to 10 * Stable medications for at least 6 months * Speak Spanish and/or English * Sign an informed consent form * No other members in their household are participating in the study Exclusion Criteria: * Patients \<21 years of age, who do not have type II DM, whose Ha1c is less than 8 or \> 10, * Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk \> 5, or history of CVD/stroke * Do not speak and understand either English or Spanish well * Allergic to cinnamon * Severe diseases, such as cancer * Compromised immune system * Eating disorders * BMI of 40 or higher * Already have a family member participating in the study * Substance use disorder

Study sites (1)

CA